<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>FICCI PRE-BUDGET MEMORANDUM 2018-2019</title>
    <link>https://www.taxtmi.com/news?id=19406</link>
    <description>The memorandum urges repeal or relaxation of anti abuse provisions including sections 56(2)(x) and 50CA, relief from MAT in insolvency resolution, retroactive amendment of section 14A for dividend income, a roadmap to reduce corporate tax rates, simplification of ICDS and deduction rules to reduce litigation, and expanded tax carve outs for insurance and re insurers. On GST it seeks reduced compliance, convergence to fewer rates, seamless input tax credit (including removal of section 17 restrictions and reversal rules for healthcare/pharma free or expired samples), clarification of HSN classifications, and sectoral zero rating or exemptions to protect domestic industry and affordability.</description>
    <language>en-us</language>
    <pubDate>Mon, 22 Jan 2018 18:25:57 +0530</pubDate>
    <lastBuildDate>Wed, 11 Feb 2026 15:57:36 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=505654" rel="self" type="application/rss+xml"/>
    <item>
      <title>FICCI PRE-BUDGET MEMORANDUM 2018-2019</title>
      <link>https://www.taxtmi.com/news?id=19406</link>
      <description>The memorandum urges repeal or relaxation of anti abuse provisions including sections 56(2)(x) and 50CA, relief from MAT in insolvency resolution, retroactive amendment of section 14A for dividend income, a roadmap to reduce corporate tax rates, simplification of ICDS and deduction rules to reduce litigation, and expanded tax carve outs for insurance and re insurers. On GST it seeks reduced compliance, convergence to fewer rates, seamless input tax credit (including removal of section 17 restrictions and reversal rules for healthcare/pharma free or expired samples), clarification of HSN classifications, and sectoral zero rating or exemptions to protect domestic industry and affordability.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Mon, 22 Jan 2018 18:25:57 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=19406</guid>
    </item>
  </channel>
</rss>